Publications du CNR en 2016

Bernard, J., Armand-Lefèvre, L., Luce, E., Mniai, A. E., Chau, F., Casalino, E., Andremont, A. and Ruppé, E. (2016). Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae. Clinical Microbiology and Infection 22, 646.e1-646.e4, http://doi.org/10.1016/j.cmi.2016.04.015.

Bernard, C., Aubry, A., Chauffour, A., Brossier, F., Robert, J. and Veziris, N. (2016). In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests. J Antimicrob Chemother, http://doi.org/10.1093/jac/dkw344.

Brossier, F. and Aubry, A. (2016). Résistance de Mycobacterium tuberculosis aux antituberculeux. Feuillets Bio 328, 17–25, http://doi.org/10.1684/abc.2016.1132.

Brossier, F., Guindo, D., Pham, A., Reibel, F., Sougakoff, W., Veziris, N. and Aubry, A. (2016). Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains. J Clin Microbiol 54, 1573–1580, http://doi.org/10.1128/JCM.00051-16.

Brossier, F., Cambau, E., Tessier, E., Jarlier, V. and Sougakoff, W. (2016). The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. Tuberculosis 101, 144–145, http://doi.org/10.1016/j.tube.2016.09.028.

Brossier, F., Boudinet, M., Jarlier, V., Petrella, S. and Sougakoff, W. (2016). Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Tuberculosis 100, 15–24, http://doi.org/10.1016/j.tube.2016.06.002.

Chauffour, A., Robert, J., Veziris, N., Aubry, A. and Jarlier, V. (2016). Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium ulcerans Infection in Mice. PLOS Neglected Tropical Diseases 10, e0005066, http://doi.org/10.1371/journal.pntd.0005066.

Chazel, M., Marchandin, H., Keck, N., Terru, D., Carrière, C., Ponsoda, M., Jacomo, V., Panteix, G., Bouzinbi, N., Bañuls, A.-L., Choisy, M., Solassol, J., Aubry, A. and Godreuil, S. (2016). Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates. Annals of Clinical Microbiology and Antimicrobials 15, 30, http://doi.org/10.1186/s12941-016-0145-1.

Crabol, Y., Catherinot, E., Veziris, N., Jullien, V. and Lortholary, O. (2016). Rifabutin: where do we stand in 2016? J Antimicrob Chemother dkw024, http://doi.org/10.1093/jac/dkw024.

Fox, G. J., Benedetti, A., Mitnick, C. D., Pai, M., Menzies, D. and Mdr-Tb, T. C. G. for M.-A. of I. P. D. in (2016). Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis. PLOS ONE 11, e0151724, http://doi.org/10.1371/journal.pone.0151724.

Fox, G. J., Mitnick, C. D., Benedetti, A., Chan, E. D., Becerra, M., Chiang, C.-Y., Keshavjee, S., Koh, W.-J., Shiraishi, Y., Viiklepp, P., Yim, J.-J., Pasvol, G., Robert, J., Shim, T. S., Shin, S. S., Menzies, Dick, Mdr-Tb, for the C. G. for M.-A. of I. P. D. in, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Burgos, M., Centis, R., Cobelens, F., Cox, H., D’Ambrosio, L., Lange, W. C. M. de, DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Hopewell, P., Iseman, M., Jarlsberg, L. G., Kim, H. R., Lancaster, J., Lange, C., Leimane, V., Leung, C. C., Li, J., Menzies, D., Migliori, G. B., Narita, M., Nathanson, E., Odendaal, R., O’Riordan, P., Pai, M., Palmero, D., Park, S. K., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M. I. D., Quy, H. T., Riekstina, V., Royce, S., Salim, M., Schaaf, H. S., Seung, K. J., Shah, L., Shean, K., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Sung, S. W., Tabarsi, P., Tupasi, T. E., Vargas, M. H., Altena, R. van, Walt, M. van der, Werf, T. S. van der, Westenhouse, J. and Yew, W. W. (2016). Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. Clin Infect Dis 62, 887–895, http://doi.org/10.1093/cid/ciw002.

Guglielmetti, L., Dû, D. L., Veziris, N., Caumes, E., Marigot-Outtandy, D., Yazdanpanah, Y., Robert, J. and Fréchet-Jachym, M. (2016). Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? European Respiratory Journal 48, 582–585, http://doi.org/10.1183/13993003.00411-2016.

Henry, B., Revest, M., Dournon, N., Epelboin, L., Mellon, G., Bellaud, G., Mordant, P., Le Dû, D., Véziris, N., Bernard, C., Morel, S., Jauréguiberry, S., Michelet, C., Bricaire, F., Tattevin, P. and Caumes, É. (2016). Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerging Infectious Diseases 22, 518–521, http://doi.org/10.3201/eid2203.151130.

Lachâtre, M., Rioux, C., Dû, D. L., Fréchet-Jachym, M., Veziris, N., Bouvet, E. and Yazdanpanah, Y. (2016). Bedaquiline plus delamanid for XDR tuberculosis. Lancet Infect Dis 16, 294, http://doi.org/10.1016/S1473-3099(16)00047-5.

Lafeuille, E., Veziris, N., Sougakoff, W., Roure, F., Le Dû, D., Dournon, N., Caumes, E., Jarlier, V., Aubry, A., Robert, J. and Bernard, C. (2016). XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions. Médecine et Maladies Infectieuses 46, 52–55, http://doi.org/10.1016/j.medmal.2015.12.008.

Lange, C., Duarte, R., Fréchet-Jachym, M., Guenther, G., Guglielmetti, L., Olaru, I. D., Oliveira, O., Rumetshofer, R., Veziris, N. and van Leth, F. (2016). Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe. Am J Respir Crit Care Med 194, 1029–1031, http://doi.org/10.1164/rccm.201606-1097LE.

Lortholary, O., Roussillon, C., Boucherie, C., Padoin, C., Chaix, M.-L., Breton, G., Rami, A., Veziris, N., Patey, O., Caumes, E., May, T., Molina, J.-M., Robert, J., Tod, M., Fagard, C. and Chêne, G. (2016). Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial. Journal of Antimicrobial Chemotherapy 71, 783–793, http://doi.org/10.1093/jac/dkv384.

Mieras, L., Anthony, R., van Brakel, W., Bratschi, M. W., van den Broek, J., Cambau, E., Cavaliero, A., Kasang, C., Perera, G., Reichman, L., Richardus, J. H., Saunderson, P., Steinmann, P. and Yew, W. W. (2016). Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy. Infectious Diseases of Poverty 5, 46, http://doi.org/10.1186/s40249-016-0140-y.

Mougari, F., Amarsy, R., Veziris, N., Bastian, S., Brossier, F., Berçot, B., Raskine, L. and Cambau, E. (2016). Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar. J Antimicrob Chemother 71, 2208–2212, http://doi.org/10.1093/jac/dkw130.

Mougari, F., Guglielmetti, L., Raskine, L., Sermet-Gaudelus, I., Veziris, N. and Cambau, E. (2016). Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Review of Anti-infective Therapy 14, 1139–1154, http://doi.org/10.1080/14787210.2016.1238304.

Pantel, A., Petrella, S., Veziris, N., Matrat, S., Bouige, A., Ferrand, H., Sougakoff, W., Mayer, C. and Aubry, A. (2016). Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis. J Antimicrob Chemother 71, 2428–2431, http://doi.org/10.1093/jac/dkw169.

Parize, P., Hamelin, A., Veziris, N., Morand, P. C., Guillemain, R., Lortholary, O. and Dupin, N. (2016). Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. Journal of the European Academy of Dermatology and Venereology 30, 101–105, http://doi.org/10.1111/jdv.12965.

Raharolahy, O., Ramarozatovo, L. S., Ranaivo, I. M., Sendrasoa, F. A., Andrianarison, M., Andrianarivelo, M. R., Cambau, E. and Rabenja, F. R. (2016). A Case of Fluoroquinolone-Resistant Leprosy Discovered after 9 Years of Misdiagnosis. Case Reports in Infectious Diseases 2016, 4632369, http://doi.org/10.1155/2016/4632369.